New radiation technique aims to reduce side effects in rectal cancer treatment
NCT ID NCT02151019
First seen Apr 25, 2026 · Last updated May 31, 2026 · Updated 8 times
Summary
This study compared two radiation methods given before surgery for locally advanced rectal cancer. The goal was to see if intensity modulated radiotherapy (IMRT) causes fewer stomach and bowel side effects than standard 3-D conformal radiotherapy. The study enrolled 94 adults and was stopped early, but the findings may help doctors choose the safer option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
St Luke's Centre for Radiation Oncology at St James Hospital
Dublin, Ireland
-
St Luke's Centre for Radiation Oncology at St Lukes Hospital
Dublin, Ireland
-
St Luke's Radiation Oncology Network at Beaumont Hospital
Dublin, 9, Ireland
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.